Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib
- Issued Date
- 2020
- Type
- Article
- Publisher
- BREAST CANCER RESEARCH AND TREATMENT
- Language
- 영어
- ISSN
- 0167-6806
- Citation Volume
- 184
- Citation Number
- 3
- Citation Start Page
- 743
- Citation End Page
- 753
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.